Why Nutritional Care Matters for People Living with Mitochondrial Disease
Good nutrition is an important part of managing many rare neuromuscular conditions, including mitochondrial diseases. A new educational flyer, funded […]
Good nutrition is an important part of managing many rare neuromuscular conditions, including mitochondrial diseases. A new educational flyer, funded […]
A significant milestone has been reached for families affected by TK2d: Germany has now formally recognised Kygevvi®, the first disease‑specific
IMP has begun hosting regular Ambassador Meetings, creating a welcoming space for representatives from our member organisations to connect, share updates,
The LHON Awareness Day Webinar is approaching quickly, taking place on 19 September (13:00–15:00 CEST). This year’s theme — Best practices in LHON: stories
Three new TK2d Awareness Day videos are being released in the lead‑up to 8 September, each sharing a deeply personal
On 10 October 2026, the European Reference Network for Rare Neurological Diseases (ERN‑RND) will host a dedicated scientific symposium focused on
A Landmark Moment for the POLG Community – 17 November 2026 On 17 November, MitoAction will host its first Patient‑Focused Drug Development
Following the POLG Foundation Summit, Pretzel Therapeutics has shared updated answers to community questions about PX578, their first‑in‑class investigational therapy for
FDA clears PX578 to enter Phase 2 clinical testing At IMP, few moments bring more hope than seeing innovative science
A new retrospective natural history study from the MitoCAMB team at the University of Cambridge offers important insights into mitochondrial neurogastrointestinal